Member Info for Tyke68

Dear Board of Directors

If you have a grand plan in the future of IBAI then could you please share it with us, the shareholders by the close of trading Tuesday 20th January 2026. We believe we need and have a right to know if our investment actually has a future.

Primarily can we be informed of any increases in revenue expected or actual in IB products and what are the plans for the GAM trial data, are the company in discussions for either licensing or sale of said data?

Thank you

Thank you for the now 5 likes

To add to the list Dr Musella was a director at the time of the Kirkstall deal and his email address is musella@virtualtrials.org

Trek

Thank you for comments yesterday, you may wish to pass the MAR details to the FT investigative journalist Dan McCrum (dan.mccrum@ft.com) . TB didn’t seem to rate another FT columnist “Lex” when he was writing his blog about being in Heidiland https://fabooks.wordpress.com/category/lex-watch-bun-rating/

Semantic you haven’t commented on yesterday’s RNS maybe you may wish to publish your thoughts on why the sudden change from the November RNS and IB not being involved in the Gabriel trial. Even though they refer to our current phase 1 clinical trial in their journal post. Indeed what happened to the discussions with prospective partners? Why have we shareholders not been informed on what with those. Funny how somethings are deemed important enough to report in an RNS but then the changes aren’t.

I think in summary in RNS’s we have been lead to believe the trial was to be continued with or without partners. Why the sudden change, if we are now solely focussed on imagery etc why did the board purchase Kirkstall?

Thank you

Semantic

We indeed does mean the shareholders of IBAI, I don’t think there is an issue and people understand that.

Thank you anyway

Thank you to those 4 likes who will also email if we don’t get some answers by Tuesday close.

Please help us to show the board our feelings towards how we are being treated

Thank you

If any True shareholders are also IBAI shareholders and are shall say we upset about the latest RNS then could I ask if you could help joining the email requests I have started over on the IBAI board.

https://www.lse.co.uk/ShareChat.html?ShareTicker=IBAI&share=Imaging-Bio

The more people who start asking for answers the better I believe.

If you aren’t invested in IBAI sorry for wasting your time. I sincerely hope the shenanigans don’t happed to yourselves.

Thank you

It is our company. We can either sit here complaining or try to do something about it. Please like if you intend to send emails. The more people the BoD sees are willing to ask questions the more likely we are to get a response.

Thank you

T

Let’s be proactive

TB can only keep getting away with all these alleged shenanigans because we let him.

I believe it is up to all shareholders to be proactive and fight back. We can’t keep complaining on here if we do nothing about it.

So I would suggest if we have had no further detailed communication from the board by Tuesday, close of trading, then I think we need to start being proactive and start asking questions. We are shareholders and deserve to know what’s happening.

So the questions I think we should focus on are relevant to the future of the company and our investment

Dear

As a concerned shareholder I would like the answers to these questions please:

What has changed since the RNS issued on 10th November 2025 which states “With Phase 1 now complete, IB is actively engaging with leading cancer centers to initiate a Phase 2 trial aimed at further evaluating GaM's efficacy and expanding its clinical footprint.”? Also, the same MCW clinical staff stated for the Gabriel trial “In our ongoing Phase 1 trial of oral GaM for adult patients with recurrent glioblastoma, GaM has been well-tolerated without significant side effects. Thus, we hypothesize GaM can be safely administered enterally to pediatric patients.” Does that mean if GaM is approved by the FDA for paediatric use that IBAI are the ones who would own the paediatric rare drug designation?

Why did we buy Kirkstall from Truetide and what was Trevor Brown’s actual involvement in the deal? Who initiated the purchase Truetide or IBAI if we are now solely focussed on imaging as Kirkstall doesn’t fit in with that?

Basically what reassurances have shareholders got for the long term future for the company and our investments?

How do know that the long term plan is not for the Kirkstall, or any subsequent deal, to lead to bankruptcy IBAI and the imaging and IP then belongs to truetide?

I would like detailed answers to these questions please as I am a shareholder in this company and would like to know what is happening to my investments and how you intend to fulfil your fiduciary responsibilities to all shareholders.

Yours truly

We all need to ask as many people as possible, individually for their response. We need our concerns on record. We need to be united and act as a group.

These are the contact details I know of

Trevor Brown email

trevorebrown@hotmail.com

Michael Schmainda email

mike@imagingbiometrics.com

Brett Skelly

brettskelly@gbac.co.uk

Gbac contact

info@gbac.co.uk

Our company secretary

Apex Group

https://www.apexgroup.com/contact-page/

Financial conduct authority

https://www.fca.org.uk/contact

Alliance news

newsroom@alliancenews.com

If anybody can think of any more relevant contact details please add to this list.

It is our company. We can either sit here complaining or try to do something about it. Please like this post if you intend to send emails. The more people the board sees are wi

But that would value KS’s share at zero as well.

Make the FCA aware that is what you believe is happening then they are complicit if it happens and they don’t investigate?

Email TB and the board and see if you get a response and use that as evidence as well if it did happen

If you feel the worst is going to happen then we become prepared and alert everybody of what you think is going to happen. Proactive rather than reactive. Don’t let them do it by making people aware now rather then complain afterwards.

We are all shareholders so need to express a united front.

Thanks

So if we defaulted on the Kirkstall loan can they takeover our assets and ip?

Is that the plan?

Was the RNS from 10th November a lie?

“With Phase 1 now complete, IB is actively engaging with leading cancer centers to initiate a Phase 2 trial aimed at further evaluating GaM's efficacy and expanding its clinical footprint.”

If it was a lie does that mean market abuse, spreading false news when it fully intended to close the trial? Just thinking about when Gabriel was initiated?

Thanks

Malletp where does it say a sale will go ahead for GaM?We are just guessing that could happen. Have you heard differing information?

Thanks

Total silence from the company today. They just don’t care.

Thanks

IBAI has currently dropped 40% today. I am surprised there hasn’t been a RNS to inform you of their decision to halt the clinical trial. I hope True shareholders is treated with more respect by the board than IBAI has been in my opinion.

BB

The company secretary contact is

https://www.apexgroup.com/contact-page/

Maybe we all need to contact them as well to ask how we can initiate an EGM? Red please don’t your shares just yet, I am sure you said you would buy more when the price dropped, well it has definitely dropped today.

Thanks

Red do you still own 6m shares or so? If so can you buy a few more and I and am sure many others on here would support you if you were to stand for the board.

Max, are you ok, no comments on today. Have you heard from MS today? I get the feeling he could be getting a few emails and not positive ones. We trusted him.

Cautious, forget the Porsche, soon I won’t be able to avoid a bus pass.

I hope people don’t drink too much drowning their sorrows their weekend. I would say it couldn’t get worse but we all know it could.

Thanks

Kane

You raise a very good point. If IB own all the data from the GaM trial then surely we are vested shareholders in the Gabriel trial if they are using our data. MS needs to explain this and any conflict of interest for KS and others has been involved in both trials and is a significant shareholder in IBAI.

Thanks

Well I think we can all agree on how TB can be judged over the last 3 years? Maybe he or semantic can over us his own judgement.

The only thing I can think of is TB/semantic has been ill and hence the silence (maybe the radiation comment was a clue) and actually doesn’t have the money himself to finance the phase 2 even though he has insinuated he would and everything has changed over the last month.

Just trying to think what has changed. Gam trial gone so well to now being closed down. What will JC/CC and indeed KS feel about this? Many years worth of work for nothing or did the trial fail and we were never told the truth?

Let’s have the truth of what is happening. Brett Skelly should be acting on our behalf please do ask him to

brettskelly@gbac.co.uk

Thanks

Brett Skelly is the chairman

brettskelly@gbac.co.uk

He is supposed to act on behalf of all shareholders so if people want to ask how he is doing this I am sure he would appreciate our comments.

Thanks

So how much of the company do we have to own to do initiate a vote of no confidence in TB and the board?Brett Skelly is the chairman so supposed to act in shareholders interest so maybe he could actually help us for once?

Thanks

What is TB’s salary as a percentage of the mcap?

It mentions shareholder value in the near future etc. that needs explaining. Is everybody suddenly using our imaging tech?